Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
44
NCT00824980
Combined Inhibition of Dipeptidyl Peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/CD13) in the Treatment of Psoriasis
Phase: Phase 2
Role: Lead Sponsor
Start: Jan 31, 2009
Completion: Sep 30, 2009
NCT06702280
Assessing the Safety of an IGY Supplement on the Gut Microbiome
Phase: Phase 1
Role: Collaborator
Start: Feb 28, 2025
Completion: Oct 31, 2025